Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV Vaccination for Refractory Cutaneous Warts
NCT05625633Phase 3Recruiting
- Sponsor
- Western Institute for Veterans Research
- Start
- Mar 2024
- Primary completion
- Dec 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human papillomavirus 9-valent vaccine in cutaneous warts, sponsored by Western Institute for Veterans Research. Started Mar 2024; status: recruiting.
02
Drugs
recombinant human papillomavirus 9-valent vaccine
03
Conditions
cutaneous warts
Beyond the preview
Go deeper on NCT05625633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05625633.